Maureen Dubreuil, MD, MSc.

Dr. Dubreuil is a rheumatologist in Boston, specializing in spondyloarthritis. She works within the Rheumatology section at Chobanian and Avedisian School of Medicine, where her research focuses on comorbidities and pharmacoepidemiology of spondyloarthritis. Dr. Dubreuil's research has been funded by numerous competitive grants from funders including the NIH, private foundations and industry. Some highlights of Dr. Dubreuil's work includes:
1. Discovery of two key protective effects of TNF inhibitors against fractures and cardiovascular events in spondyloarthritis
2. Finding that a common nonsteroidal anti-inflammatory drug is associated with 3 times the risk of heart attack among people with spondyloarthritis
3. Development of the first North American guidelines for referral of adults at increased risk of having spondyloarthritis to a rheumatologist

In addition to her research, Dr. Dubreuil is a member of the leading international organizations for spondyloarthritis research. She serves on the Executive Committee of the Board of Directors for the Spondyloarthritis Research and Treatment Network, and on the Medical Advisory Board for the Spondylitis Association of America. She is a site investigator for the international CLASSIC study in spondyloarthritis. Dr. Dubreuil is the Director of Research Training for the Rheumatology Fellowship program at Boston Medical Center.

Dr. Dubreuil cares for people with rheumatic conditions at Boston Medical Center and the VA Boston Healthcare System. Dr. Dubreuil's patients say the following about her:
"Dr. Dubreuil is a very caring and knowledgeable doctor and it's always a pleasure to be seen by her."
"I am very satisfied with the care I have received. My provider and the support staff is very professional, caring and concerned. I would recommend to anyone."
"Dr. Dubreuil is a gem and I feel so lucky to have her!"
A survey of 40 patients who received care by Dr. Dubreuil in 2024-2025 found that 100% would recommend her!

Diversity, Equity, Inclusion and Accessibility

Dr. Dubreuil is a participant in the Rheumatology Section monthly journal club focused on Justice, Equity, Diversity and Inclusion (JEDI).
Additionally, as a leader for the weekly Research Accelerator meeting, Dr. Dubreuil addresses topic of research equity, and guides discussion around studies addressing disparities in treatment and outcomes.
Dr. Dubreuil was the invited moderator for the 2023 Unmet Research Needs in Spondyloarthritis session on Health Outcomes, Social Constructs and Disparities.
Additionally Dr. Dubreuil is grateful to be the recipient of grant funding from the Arthritis Foundation to study disparities in time to diagnosis of Axial Spondyloarthritis: https://stage.arthritis.org/news/stories-of-yes/2022-dei-award-maureen-dubreuil

Member
Boston University
Arthritis & Autoimmune Diseases Research Center


VA Boston Healthcare System




Protocol I1F-MC-B019: Psoriatic Arthritis Real-World Study in the US (PARTUS)
10/17/2023 - 10/17/2027 (Subcontract PI)
United BioSource LLC Eli Lilly and Co


COLLECTION OF PERIPHERAL BLOOD MONONUCLEAR CELLS FROM PATIENTS WITH HLA-B27+ RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS
07/22/2025 - 07/22/2026 (PI)
Hillstar Bio


SPARTAN Referral Recommendations
07/01/2021 - 12/31/2025 (PI)
SpondyloArthritis Research and Treatment Network


Delay in diagnosis of ankylosing spondylitis: Do race, ethnicity or social determinants of health matter?
01/01/2023 - 06/30/2025 (PI)
Arthritis Foundation


Effects of Janus kinase inhibitors on structural and safety outcomes in spondyloarthritis
06/16/2022 - 12/31/2024 (PI)
Pfizer, Inc.


Career Development Bridge Funding Award: R Bridge
11/01/2022 - 10/30/2024 (PI)
Rheumatology Research Foundation


Risk of fractures, joint replacements and adverse pregnancy outcomes in ankylosing spondylitis
07/01/2020 - 06/30/2023 (PI)
NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases
5R03AR076495-02

Classification of Axial SpondyloarthritiS Inception Cohort (CLASSIC)
12/23/2019 - 12/22/2022 (PI)
SpondyloArthritis Research and Treatment Network


Establishing The Value of Treatment Strategies in Spondyloarthritis
05/01/2016 - 04/30/2022 (PI)
NIH/National Institute of Arthritis & Musculoskeletal & Skin Diseases
5K23AR069127-05

Cardiovascular disease and diabetes in Ankylosing Spondylitis
07/01/2013 - 12/30/2015 (PI)
Arthritis Foundation



Boston University Advanced Fellowship in Psoriatic Arthritis Clinical and Research Excellence
07/01/2020 - 06/30/2025 (PI)
Pfizer, Inc



Title

Boston University Clinical and Translational Science Institute
01/01/2019 - 12/31/2020 (PI)
BU CTSI

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Degirmenci HB, Peloquin CE, Westerland M, Lodi S, Machado PM, Jafarzadeh SR, Neogi T, Gensler LS, Dubreuil M, Liew JW. Trends in Opioid Prescriptions in Individuals With Axial Spondyloarthritis in the United States and United Kingdom in the Last Two Decades: Analysis of Electronic Health Records and Insurance Claims Data. Arthritis Care Res (Hoboken). 2025 Sep 22.View Related Profiles. PMID: 40977482; PMCID: PMC12462897; DOI: 10.1002/acr.25655;
     
  2. Achkar A, Peloquin C, Liew JW, Dubreuil M. Targeted and biologic therapies and risk of total knee or hip replacement in axial spondyloarthritis and psoriatic arthritis. Clin Rheumatol. 2025 Oct; 44(10):4005-4013.View Related Profiles. PMID: 40936006; PMCID: PMC12435908; DOI: 10.1007/s10067-025-07666-8;
     
  3. Dubreuil M, Walsh JA, Deodhar A, Gensler LS, Curtis JR, Welby S, Pilipczuk O, Beaty S, Mørup MF, Taieb V, Anjohrin S. Real-World Use of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Axial Spondyloarthritis in the United States: Persistence, Variables Associated With Persistence, and Dosing Variations. Pharmacoepidemiol Drug Saf. 2025 Sep; 34(9):e70197. PMID: 40854555
     
  4. Dubreuil M, Magrey M, Haeffs K, Ivanov E, Gandrup Horan J. Patient Diagnostic Journey and Time to Diagnosis in Axial Spondyloarthritis: A Retrospective Cohort Study Using US Claims Data. Rheumatol Ther. 2025 Oct; 12(5):991-1006. PMID: 40879862; PMCID: PMC12450132; DOI: 10.1007/s40744-025-00791-5;
     
  5. Sendaydiego X, Gold LS, Dubreuil M, Andrews JS, Reid P, Liew DFL, Goulabchand R, Hughes GC, Sparks JA, Jarvik JG, Singh S, Liew JW, Singh N. Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritis. Rheumatology (Oxford). 2025 Jun 01; 64(6):3434-3443.View Related Profiles. PMID: 39936579; PMCID: PMC12107039; DOI: 10.1093/rheumatology/keaf096;
     
  6. Neogi T, Dubreuil M, Peloquin C, Marinko L, Camarinos J, Felson DT, Kumar D. Reply. Arthritis Rheumatol. 2025 Nov; 77(11):1611-1612.View Related Profiles. PMID: 40289862; PMCID: PMC12313301; DOI: 10.1002/art.43202;
     
  7. Neogi T, Dubreuil M, Peloquin C, Marinko L, Camarinos J, Felson DT, Kumar D. Association of Physical Therapy Care With Use of Intra-Articular Injections in People With Knee Osteoarthritis: A Real-World Cohort Study. Arthritis Rheumatol. 2025 Aug; 77(8):1006-1014.View Related Profiles. PMID: 40091450; PMCID: PMC12313411; DOI: 10.1002/art.43155;
     
  8. Ferrandiz-Espadin R, Rabasa G, Gasman S, McGinley B, Stovall R, Jafarzadeh SR, Liew JW, Dubreuil M. Disparities in Time to Diagnosis of Radiographic Axial Spondyloarthritis. J Rheumatol. 2025 Apr 01; 52(4):344-351.View Related Profiles. PMID: 39486857; PMCID: PMC11961325; DOI: 10.3899/jrheum.2024-0574;
     
  9. Ualiyeva S, Basu A, Roguski M, Degirmenci HB, Dubreuil M, Erdil RM, Garibyan L, Arkun K. Molecular detection of Tropheryma whipplei DNA: a crucial tool for diagnosing Whipple's disease in the brain. Illustrative case. J Neurosurg Case Lessons. 2025 Mar 24; 9(12).View Related Profiles. PMID: 40127479; PMCID: PMC11933666; DOI: 10.3171/CASE24687;
     
  10. Choufani M, Ghusn W, Dubreuil M, Ermann J. Diversity in Axial Spondyloarthritis Drug Trials: Enrollment by Sex, Race, Ethnicity, and Geographic Region. J Rheumatol. 2025 Mar 15. PMID: 40089303; PMCID: PMC12353359; DOI: 10.3899/jrheum.2024-1013;
     
Showing 10 of 81 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 81 publications over 16 distinct years, with a maximum of 14 publications in 2025

YearPublications
20091
20101
20121
20134
20141
20152
20165
20175
20187
20195
20207
202113
20221
20237
20247
202514

2024-2025 Boston Medical Center/Boston University Department of Medicine: R Bridge Award
2023-2024 Boston University Chobanian & Avedisian School of Medicine, Department of Medicine: R Bridge Award
2022-2023 Doris Duke Charitable Foundation: Scientist Retention Award
2022-2024 Rheumatology Research Foundation: R Bridge Award
2022-2024 Boston University Clinical and Translational Science Institute: Informatics Award (UL1 TR 001430)
2022-2023 Arthritis Foundation: Research Grant: "Delay in diagnosis of ankylosing spondylitis"
2022-2024 Pfizer: Investigator-Initiated Research Grant: "Effects of Janus kinase inhibitors in spondyloarthritis"
2022-2024 Spondyloarthritis Research and Treatment Network: Project Award: "Development of Referral Recommendations in Spondyloarthritis"
2020-2022 NIH/NIAMS: R03: "Risk of Fractures & Joint Replacement Surgeries w/TNF-inhibitors in Ankylosing Spondylitis"
2019-2020 Boston University Clinical and Translational Science Institute: Pilot Grant: “Risk of joint replacement surgery in ankylosing spondylitis”
2018 Spondylitis Association of America:: Early Career Investigator Award
2018 Spondyloarthritis Research and Treatment Network : Seed Grant
2017 Boston University Department of Medicine: Evans Junior Merit Award
2016-2021 NIH/NIAMS: K23 Career Dev. Grant: "Establishing the Value of Treatment Strategies in Ankylosing Spondylitis"
2016-2020 Boston University School of Public Health and Optum Labs Visiting Scholar
2016-2017 Boston University Clinical and Translational Science Institute: Pilot Grant: “Identifying incident cases of knee osteoarthritis in THIN, a large database”
2015-2020 Boston University Department of Medicine: Career Investment Award
2013-2015 Arthritis Foundation: Research Scientist Development Award
2011-2013 NIH/NIAMS: T32 Training Grant
2009 Gold Humanism in Medicine Award
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Spondyloarthritis, Ankylosing
Psoriatic Arthritis
Epidemiology
Pharmacoepidemiology
NSAIDs
Spondyloarthropathies
Spondyloarthritides, Ankylosing

I have mentored Master-level SPH students and fellows in projects related to epidemiology of rheumatologic diseases and pharmacoepidemiology. These projects have culminated in publications, a Master degree thesis, as well as poster and oral presentations at national meetings. I hope to continue mentoring trainees who have interests in epidemiology related to specific research projects, development of research themes, or development of grant applications.

Available to Mentor as: (Review Mentor Role Definitions):
  • Co-Mentor or Peer Mentor
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')
Dubreuil's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department